CSIMarket Company Name, Ticker, Suppliers, else..
 
Nemaura Medical Inc   (NMRD)
Other Ticker:  
 
 
Price: $0.0002 $0.00 0.000%
Day's High: $0.0002 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: 0.00
Volume (M): 2 52 Wk High: $ 0.06
Volume (M$): $ 0 52 Wk Avg: $0.03
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 31
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 0

Nemaura Medical Inc
Nemaura Medical Inc is a medical technology company that focuses on the development, manufacturing, and commercialization of non-invasive medical devices. Their flagship product is the SugarBEAT system, which is a wearable patch that allows users to monitor their glucose levels continuously throughout the day. The company aims to provide convenient and affordable glucose monitoring solutions for people with diabetes. In addition to diabetes management, Nemaura Medical also develops other healthcare technologies, such as the proBEAT system for non-invasive blood pressure monitoring. The company is headquartered in the UK and operates globally through partnerships and distribution agreements.


   Company Address: 57 West 57th Street Manhattan 10019 NY
   Company Phone Number: 416-8000   Stock Exchange / Ticker: NMRD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DRIO      % 
DXCM      % 
EMBC      % 
MDT      % 
PODD      % 
TNDM      % 
• View Complete Report
   



Nemaura Medical Inc

Nemaura Medical Inc Maintains Break-Even but Faces Increased Net Deficit in Financial Span Ending December 31, 2023

/>In the financial span ending December 31, 2023, Nemaura Medical Inc, a medical technology company, achieved a break-even of $0.00 per share, compared to a loss of $0.07 per share a year ago and maintaining the same level as the prior reporting period. However, the company's net deficit increased to $-2.161 million, compared to $-1.716 million in the previous year. This report aims to provide a comprehensive overview of Nemaura Medical Inc's financial performance and key highlights.
Financial Performance:
Despite achieving break-even in the final quarter of 2023, Nemaura Medical Inc's revenues remained unchanged at $0.00 million from the same reporting period a year ago, as well as sequentially.
Nemaura Medical Inc

Nemaura Medical Inc Reports Disappointing Second Quarter Earnings, Faces Concerns Over Inventory



Nemaura Medical Inc, a healthcare technology company, recently reported its earnings for the second quarter of the 2024 fiscal year. Unfortunately, the results were disappointing, reflecting a continued downward trend from the previous year. Additionally, the company's increasing inventories are a cause for concern. This bearish analysis examines the financial performance of Nemaura Medical Inc and discusses the key factors contributing to its downward trajectory.
Earnings Performance
During the second quarter of the 2024 earnings season, Nemaura Medical Inc recorded an earnings-per-share (EPS) of $0.00. This represents no growth compared to the same reporting period a year before. Moreover, it is evident that the company's profitability has stagnated, as it failed to generate any positive earnings. Previous financial results also showed a net deficit of $-1.203 million, a slight improvement from the $-3.856 million deficit reported during the same period last year. However, this improvement is not substantial enough to warrant confidence in Nemaura Medical Inc's financial health.
Nemaura Medical Inc

Nemaura Medical Inc Surpasses Expectations with Improved Financial Performance in Q1 2024


Subtitle: A closer look at the recent financial results and market performance
As an avid investor in the Medical Equipment & Supplies industry, I have been closely monitoring the financial results of companies within the sector. The recent financial results of Nemaura Medical Inc have caught my attention due to their significant impact on the company's overall performance and market position.
According to the company's first-quarter report for 2024, Nemaura Medical Inc announced an operating deficit of $-1.834142 million. Comparing this to the previous year's first quarter, where the operating deficit was at $-2.43689 million, it is evident that Nemaura Medical Inc has made progress in improving its financial condition. This positive trajectory is an encouraging sign for investors who are closely observing the company's growth potential.
Nemaura Medical Inc

Nemaura Medical Inc Navigates Surprising Twist in Q4 2023 Financial Results Amid Decline in Per Share Income

Nemaura Medical Inc (NASDAQ: NMRD), a leading Medical Equipment & Supplies company, recently released its financial results for the first quarter, ending March 31, 2023. Despite reporting a decline in income compared to the previous year, the company remains confident in its ability to rebound and achieve sustainable growth in the future.
During the first quarter, Nemaura Medical Inc witnessed a decrease in income, with earnings falling by -11.36% to $0.39 per share, in contrast to $0.44 per share during the same period the previous year. The company experienced a net shortfall of $-4.683 million, which was higher than the $-3.617 million in the prior year.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com